Dr. Omid Hamid
Claim this profileThe Angeles Clinic and Research Institute
Expert in Melanoma
Studies Solid Tumors
22 reported clinical trials
61 drugs studied
About Omid Hamid
Education:
- Earned an MD from the University of Southern California (USC) Keck School of Medicine, 1999.
- Completed Internship and Residency at Los Angeles County Hospital/USC Medical Center, 2000-2002.
- Completed Fellowship at USC Norris Comprehensive Cancer Center, 2005.
Experience:
- Chief of Translational Research and Immuno-Oncology at The Angeles Clinic and Research Institute.
- Director of Cutaneous Malignancies and Experimental Therapeutics at The Angeles Clinic and Research Institute.
- Professor in the Department of Medicine at Cedars-Sinai Medical Center.
- Specializes in immunotherapy and Phase I drug development for melanoma and other cancers.
Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
BRAF positive
2Solid Tumors
Stage IV
Stage III
HLA-A positive
Affiliated Hospitals
Clinical Trials Omid Hamid is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
IMC-F106C Combinations
for Solid Cancers
This trial tests IMC-F106C, a treatment that helps the immune system target and kill cancer cells in adults with advanced cancers. It guides immune cells to attack cancer cells more effectively.
Recruiting1 award Phase 1 & 2
More about Omid Hamid
Clinical Trial Related2 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Omid Hamid has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- PD-1 Inhibitor
- Docetaxel
- Capecitabine
Breakdown of trials Omid Hamid has run
Melanoma
Solid Tumors
Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Omid Hamid specialize in?
Omid Hamid focuses on Melanoma and Solid Tumors. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Omid Hamid currently recruiting for clinical trials?
Yes, Omid Hamid is currently recruiting for 10 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Omid Hamid has studied deeply?
Yes, Omid Hamid has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Omid Hamid?
Apply for one of the trials that Omid Hamid is conducting.
What is the office address of Omid Hamid?
The office of Omid Hamid is located at: The Angeles Clinic and Research Institute, Los Angeles, California 90025 United States. This is the address for their practice at the The Angeles Clinic and Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.